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Objectives: to review our experience of the endovascular management of upper limb embolisation secondary to an
ipsilateral proximal arterial lesion.
Design: a retrospective study.
Materials and methods: over 3 years, 17 patients presented with blue fingers secondary to an ipsilateral proximal
vascular lesion. These have been managed using transluminal angioplasty (14) and arterial stenting (five), combined with
embolectomy (two) and anticoagulation (three)/anti-platelet therapy (14).
Results: all the patients were treated successfully. There have been no further symptomatic embolic episodes originating
from any of the treated lesions, and no surgical amputations. Complications were associated with the use of brachial
arteriotomy for vascular access.
Conclusions: endovascular techniques are safe and effective in the management of upper limb embolic phenomena
associated with an ipsilateral proximal focal vascular lesion.
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Introduction Patients and Methods
The phenomenon of peripheral embolisation from a Over a period of 3 years we have treated 17 patients
proximal arterial lesion is well recognised. Micro- referred with sudden onset of ischaemic lesions af-
emboli from such lesions may occlude digital arteries, fecting one or more fingers of one hand consistent
most commonly in the feet, resulting in the blue toe with a diagnosis of “blue finger syndrome”. These
syndrome as described by Karmody.1 The condition patients were treated at three different vascular centres
is associated with a significant risk of further micro- and included both acute referrals, and referrals fol-
embolisation or macroembolisation threatening the lowing an earlier symptomatic episode. The group
viability of the involved limb. Several series have consisted of 14 women and three men with a mean
described the management of patients with blue toe age of 58 years (range 32–86 years years). Fourteen
syndrome, both by surgical1–3 and, more recently, by had a history of smoking, three were diabetic and one
endovascular techniques.4–6 However, few cases of the had had radiotherapy to the axilla for breast carcinoma.
upper limb equivalent, blue finger syndrome, have One patient had had previous surgery for a cervical
been reported. We present our experience of treating rib.
patients with blue finger syndrome, using a variety of The patients’ records were reviewed to determine
endovascular techniques. the presenting signs and symptoms, including, where
documented, the palpable pulses in the symptomatic
arm and the brachial–brachial index (BBI – brachial
arterial pressure in the symptomatic arm divided by
that in the contralateral arm). The angiographic lesions
identified and the subsequent interventional pro-
* Please address all correspondence to: P. A. Gaines, The Sheffield cedures performed were noted, together with the im-Vascular Institute, Northern General Hospital, Herries Road,
Sheffield S5 7AU, U.K. mediate results of such treatment, including the post
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treatment BBI. Complementary medical treatment was patient (KD) was proximal thrombus found associated
with a subclavian stenosis together with distal throm-also recorded. A combination of case note review
and contacting the patient’s general practitioner, other boembolus at the brachial bifurcation. Fourteen
patients with stenotic lesions were treated by balloonclinician, or the patient him- or herself was used to
determine the subsequent efficacy of the treatment, angioplasty in the first instance, with subsequent stent
placement in two for significant residual stenoses.particularly regarding any further embolic events. Any
subsequent imaging of the relevant vessels was also The patient who had a stenosis following axillary
radiotherapy (MC) was stented de novo. In one patientrecorded.
(LC) the stenotic lesion was overlying the origin of
the vertebral artery, in which there was still antegrade
flow. A 3F balloon catheter was therefore used to
Results occlude the vertebral artery during subclavian an-
gioplasty, to reduce the risk of cerebral embolisation.
Presenting features Eleven of these patients were continued on long-term
aspirin 150 mg per day, nine patients had heparin, and
A total of 17 patients presented with either “blue two patients had long-term warfarin (including the
finger” (digital microembolisation) or blue hands patient with visible thrombus on the subclavian sten-
(macroembolisation). osis). Two patients also had an iloprost infusion, one
Fourteen patients initially presented with signs of of whom was intolerant of aspirin.
digital microembolisation including one or more blue
fingers (13), splinter haemorrhages (three) and ul- Aneurysmal disease. One patient (EB) had an aneurysm
ceration (two). Of these, five first presented to other immediately distal to a previously resected cervical
centres who subsequently referred them on for further rib which was treated with a covered stent (Cragg
management. Four of these had been started on aspirin, endoprosthesis). A second patient (MB) had an ab-
and did not have any further embolic episodes in the errant right subclavian artery with an aneurysm seg-
intervening period. However, one patient, who was ment containing thrombus. A Wallstent was placed to
not treated with aspirin or warfarin, represented with stabilise the thrombus. Both patients were treated with
new signs of macroembolisation including a blue hand aspirin and heparin and the patient with the abberant
and loss of previously recorded radial and ulnar pulses right subclavian artery aneurysm was continued on
(KD – Table 1). Only four patients with clinical micro- long term warfarin.
embolisation had normal peripheral pulses in the
symptomatic arm. One patient (CF), who had an oc-
Approach. Endovascular treatment of the vascular le-cluded haemodialysis arteriovenous fistula, had nor-
sions was performed using a variety of vascular accessmal brachial and ulnar pulses but an absent radial
routes including brachial (either percutaneous or sur-pulse. The remainder had weak or absent brachial,
gical cut down), femoral and combined brachial andradial, and ulnar pulses due to the proximal vascular
femoral access. In two patients the use of a surgicallesion.
brachial cut down permitted balloon embolectomy ofThree patients had evidence of macroembolisation
thrombus lodged at the brachial bifurcation, and also inwith blue hands, at initial presentation. All patients
one case (KD), removal of thrombus on the subclavianwith macroembolisation had normal brachial pulses
stenosis.and absent radial or ulnar pulses.
Two patients gave a history of paraesthesia in the
symptomatic hand, but only one patient described
symptoms of arm claudication.
Outcome
The primary treatment was technically successful in
all the patients (residual stenosis of less than 50%,Investigation and treatment
exclusion of the aneurysm, completed embolectomy)
and the patients have been followed-up for a mean ofStenotic disease. At angiography 15 of the patients
13.7 months (range 3–36 months).were found to have proximal stenotic lesions in the
symptomatic arm, with a marked left sided pre-
ponderance (Table 1). The recorded BBIs in this group Stenotic disease. In the patients with stenotic lesions the
BBIs recorded following treatment were in the rangewere in the range 0.62–1.0 (median 0.78). In only one
Eur J Vasc Endovasc Surg Vol 17, February 1999
P. A. Gaines et al.108
Table 1. Angiographic findings, their treatment and outcomes in 17 patients with blue finger syndrome
Case Age Sex Risk factors Signal/ Angiographical Intervention Medical Follow Outcome Vascular imaging
initials symptoms findings* treatment up
KD 39 F Smoker Blue left hand L SA stenosis Embolectomy Heparin/ 14 m Occasional Duplex – 14m
SA thrombus Angioplasty warfarin paraesthesia Normal SA
BA thrombus
SB 47 M Smoker Ulcer left finger L SA stenosis Angioplasty Aspirin 22 m Asymptomatic None
Hypertension Ulcer healed
SM 56 F Ex-smoker Blue left finger L SA stenosis Angioplasty Heparin 31 m Asymptomatic Duplex – 7 m
Aspirin finger tip auto- No significant re-
amputated stenosis
AT 32 F Smoker Blue left finger L SA stenosis Angioplasty Aspirin 20 m Asymptomatic None
EB 86 F Smoker Blue right hand R SA/AA Embolectomy Heparin 24 m Transient Angiography –
surgery aneurysm Cragg stent Aspirin claudication – 6 m
for right BA thrombus 6 m, now Stent occluded
cervical rib asymptomatic
LC 69 F Smoker Blue left finger L SA stenosis Angioplasty Heparin/ 6 w Asymptomatic None
Hypertension warfarin until death
MB 66 F Smoker Blue right finger R SA Wallstent Heparin/ 13 m Asymptomatic Duplex – 13 m
(aberrant) warfarin > Stent patent
aneurysm aspirin
SA thrombus
EH 69 F Smoker Blue left finger L SA stenosis Angioplasty Aspirin 7 m Asymptomatic None
Hypertension Claudication Palmaz Stent
MW 79 F Smoker Blue right finger R SA Angioplasty Iloprost 9 m Asymptomatic Duplex – 9 m
stenosis Aspirin No significant
re-stenosis
JG 39 F None Blue left finger L SA stenosis Angioplasty Iloprost 15 m Asymptomatic None
Aspirin
RP 61 M Smoker Blue left finger L SA stenosis Angioplasty Heparin 36 m Asymptomatic Duplex – 36 m
BA thrombus Aspirin Recurrent SA
stenosis
AA 54 F Smoker Blue left finger L SA stenosis Angioplasty Heparin 12 m Asymptomatic None
Splinter Aspirin finger tip auto-
haemorrhage amputating
WS 77 M Smoker Blue right finger R SA stenosis Angioplasty Heparin 8 m Asymptomatic None
Aspirin
JS 57 F Smoker Blue left hand L SA stenosis Angioplasty 5 m Asymptomatic None
UA thrombus
BS 72 F Diabetes Blue left finger L SA stenosis Angioplasty Heparin 4 m Asymptomatic Duplex – 4 m
mellitus Ulcer Strecker Stent Aspirin ulcer healed No significant re-
Hypertension stenosis
CF 45 F Smoker Blue left fingers L SA stenosis Angioplasty Heparin 5 m Asymptomatic Duplex – 2 m
Diabetes Splinter Aspirin SA patent BA
mellitus haemorrhages occluded
MC 42 F R axillary Splinter R SA/AA stenosis Memotherm Heparin 3 m Forearm/hand Duplex – 3 w




*SA: subclavian artery; AA: axillary artery; BA: brachial artery; UA: ulnar artery.
0.86–1.12 (median 0.95). The only immediate com- arteriotomy site 2 months following treatment. There
has been healing of the lesions in both the patientsplication encountered was when, for technical reasons,
a stent was deployed distal to the stenotic lesion being who presented with finger ulceration. Two patients
whose blue fingers developed gangrenous tips, havetreated (CF). The stenosis was then dilated from the
brachial approach, but the deflated balloon could not either undergone, or are proceeding to spontaneous
auto-amputation. One patient, who had not had anybe withdrawn through the stent without displacing it,
and it had to be recovered via the femoral artery. further vascular symptoms, died 6 weeks after treat-
ment from an unrelated illness. Two patients haveFourteen people have remained asymptomatic even
though one case developed a recurrent stenosis at 3 had further symptoms following initial treatment. One
patient has continued to have occasional paraesthesiayears (on ultrasound) and another, whilst the sub-
clavian angioplasty site remained patent, occluded the in the finger that had been the site of microembolisation
at presentation, but has had no new symptoms fol-distal axillary and brachial artery proximal to the
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lowing treatment. The second patient (MC) developed addition, endothelial lesions causing little or no sten-
pain in the forearm and hand 3 weeks after having a osis can still be the origin of distal emboli. As a result,
stent inserted via a brachial cut down. The brachial signs and symptoms of micro- or macroembolisation
artery was re-explored and clot removed from the may be the only presenting features of the syndrome,
brachial artery which was thought to be related to an and whilst the possibility of a cardiac origin should
intimal flap at the arteriotomy site. The artery was be considered, a proximal vascular lesion in the af-
repaired and the patient has subsequently remained fected arm should be sought, and if present, treated.
asymptomatic. Endovascular therapy, using balloon angioplasty or
stents, is aimed at correcting these abnormalities by
establishing more normal flow patterns, and stimu-Aneurysmal disease. Six months after treatment, the
lating the formation of a stable neo-intima. Angioplastypatient who had a covered stent inserted for an an-
alone is usually sufficient treatment for simple stenoticeurysm, developed arm claudication. An angiogram
lesions, but significant residual stenoses, eccentric sten-confirmed occlusion of the stent, which was thought
oses and aneurysms may all benefit from the use ofto be due to poor alignment of the stent within the
stents.artery because of the rigidity of the device. There was,
Compared with the blue toe syndrome, a numberhowever, good distal collateral flow. Her symptoms
of different techniques and access may be required forsoon resolved and she remains asymptomatic. The
the successful endovascular treatment of blue fingersecond patient with aneurysmal disease remains
syndrome. Angioplasty of subclavian and axillaryasymptomatic.
stenoses is now a well-recognised and accepted tech-
nique, with a predominance of left-sided lesions often
being reported.9,10 It often benefits from the use of a
brachial approach, which provides both greater sta-
Discussion bility when trying to cross a difficult stenosis, fre-
quently near the origin of the vessel, and also a
The blue finger syndrome is uncommon. Whilst there straighter route which aids both angioplasty and stentare no randomised trials to compare any intervention
deployment. Combined brachial and femoral access(conventional surgical or endovascular) against best
allows simultaneous vascular imaging during themedical therapy, it would seem reasonable to correct
interventional procedure. A surgical arteriotomy maythe underlying source of emboli to stop further events,
facilitate brachial access, particularly if the brachialand, where the lesion is occlusive, improve flow to
artery is not palpable. If there is intravascular throm-the threatened tissue. As illustrated by one of our
bus present, either proximally or distally, then ballooncases (KD), if treatment is delayed then further micro-
embolectomy can be performed at the same time asor macroemboli may threatent the viability of the arm.
treatment of the proximal vascular lesion. SubclavianVascular lesions may give rise to emboli of several
angioplasty also carries the additional risk of vertebraldifferent types including cholesterol-rich debris and
embolisation and occlusion, particularly if the lesionfibrinoplatelet material, which cause micro-
is close to the origin of the vertebral artery. In someembolisation, and larger thrombi which cause macro-
patients the subclavian steal phenomenon may provideembolisation.1–6 Fibrinoplatelet material probably
protection, but this is not always the case (e.g. LC),accounts for most microemboli in blue digit syn-
and balloon occlusion of the vertebral artery duringdrome,1,4,6 and this is supported by the reported ef-
angioplasty may be indicated.11 The use of a Wallstentfectiveness of antiplatelet/anticoagulant therapy in
to manage loose thrombus within an anomalous sub-such patients.4,7 However, this treatment alone is not
clavian artery aneurysm is novel and clearly wouldalways sufficient. One patient (EB) was already on
not be appropriate where the aneurysm was having along-term aspirin when she first presented with em-
mass effect.bolic symptoms. The formation of fibrinoplatelet ma-
In our series of 17 patients with blue finger syn-terial is triggered by a combination of abnormal
drome, endovascular treatment combined with anti-vascular endothelium and/or abnormal flow within
platelet/anticoagulant therapy has proved to bethe vessel. The underlying proximal lesion may be
effective in preventing further emboli from a varietyrecognised as an area of intimal irregularity, which
of underlying proximal vascular lesions. Recurrentmay or may not be haemodynamically significant, or
stenoses may develop (e.g. RP) but the more stablemay take the form of an aneurysm. Patients often do
neointima has so far not led to any new embolicnot give a history of arm claudication, even if there
is a haemodynamically significant stenotic lesion. In episodes. Two patients developed brachial thrombus/
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occlusion soon after having a brachial arteriotomy with the blue-finger syndrome due to proximal arterial
disease should primarily be treated using endo-which was thought most likely to represent a local
complication of the arteriotomy. Only one patient was vascular techniques.
asymptomatic but arteriotomy should probably be
restricted to the more complex cases. Two patients had
minor ischaemic tissue loss but no patients required
a surgical amputation. No patients have had recurrent
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